Clinical Trials

Inclusion Criteria:

• Adults aged 18 to 60 (men or women).
• Hip pain for greater than 3 months that has failed non-operative treatment (physical therapy, NSAIDS, rest).
• FAI documented on X-Ray or Magnetic resonance imaging (MRI) or magnetic resonance arthrogram (MRA).
• Intraoperative labral repair or intact labrum.
• Informed consent from the participant.
• Ability to comprehend and speak English and the study design.

Pre-operative Exclusion Criteria are the following:

• Hypermobility/Ehlers-Danlos syndrome.
• Evidence of hip dysplasia (Center edge angle less than 20).
• Previous surgery or trauma of the affected hip.
• Severe acetabular deformities such as circumferential labral ossification, acetabular protrusion.
• Inflammatory/ autoimmune disease.
• Immunosuppressant medication.
• Significant medical co-morbidities such as uncontrolled diabetes, hypertension, congestive heart failure, etc.
• Severe mental or physical disability requiring assistance in daily living.
• History of pediatric hip disease with previous operation (developmental dysplasia, Legg-Calve-Perthes, Slipped capital femoral epiphysis).
• Presence of advanced hip osteoarthritis (Tonnis grade 2 or 3).
• Worker's compensation status.
• Intraoperative microfracture, or other procedure that would alter postoperative rehabilitation.
• Intraoperative labral debridement or labral reconstruction.
• Peri-trochanteric or deep gluteal space arthroscopy.
• Avascular necrosis.

Intra-operative Exclusion Criteria are the following:

• Labral debridement.
• Labral reconstruction.
• Poor quality capsular tissue.
• Hyperlaxity based on excessive subluxation of the joint greater than 2 cm with standard 50 pounds of traction.
• MFX procedures that would change post-op rehabilitation are excluded.